Logo image
Sign in
Phase III randomized clinical trial of cisplatin plus paclitaxel vs the non-platinum chemotherapy doublet of topotecan plus paclitaxel in women with recurrent, persistent, or advanced cervical carcinoma: A Gynecologic Oncology Group study
Journal article   Peer reviewed

Phase III randomized clinical trial of cisplatin plus paclitaxel vs the non-platinum chemotherapy doublet of topotecan plus paclitaxel in women with recurrent, persistent, or advanced cervical carcinoma: A Gynecologic Oncology Group study

K. Tewari, M. Sill, B. Monk, H. Long, L. Ramondetta, L. Landrum, A. Oaknin, T. Reid, M. Leitao and H. Michael
Gynecologic oncology, Vol.130(1), pp.e2-e2
07/2013

Metrics

1 Record Views

Details